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TO THE EDITOR
The common inherited skin disorder
ichthyosis vulgaris (IV; OMIM 146700)
results from mutations in the gene
encoding filaggrin (FLG), the keratin
filament aggregating protein. Recently,
the homozygous or compound hetero-
zygous loss-of-function mutations
p.R501X and c.2282del4 in FLG have
been identified in moderate or severe
IV patients from Ireland, Scotland, and
USA (Smith et al., 2006). These variants
are carried by B9% of European
people and were also revealed to be
an important predisposing factor for
atopic dermatitis (AD; Palmer et al.,
2006). Meanwhile, c.3321delA and
p.S2554X mutations in FLG were iden-
tified in Japanese IV and AD patients
(Nomura et al., 2007). Here, we per-
formed direct sequencing of FLG in an
additional Japanese family with IV
complicated by AD, as well as screen-
ing for the above mutations. Analysis
revealed compound heterozygous
p.R501X and c.3321delA mutations.
The family was Japanese and in-
cluded three affected individuals from
two generations. The most severely
affected boy was first referred to us
when he was 7 years old. He showed
diffuse, fine superficial scaling on the
lower abdomen, and extensor surfaces
of the extremities (Figure 1a). Later, he
developed severe AD (Figure 1b). The
4-year-old younger sister of this patient
was also severely affected with IV and
had mild AD. The patient and his sister
also developed asthma in early child-
hood. Although the mother showed
mild scaling at a younger age, neither
parent had atopic diathesis.
All described studies were per-
formed following the medical ethical
committee of Kurume University
School of Medicine. Written informed
consent was obtained from each indi-
viduals and the study was conducted
according to the Declaration of Helsin-
ki Principles. Genomic DNA from all
family members was extracted from
peripheral blood samples using stan-
dard methods. For FLG mutation ana-
lysis, PCR fragments were amplified as
described previously (Smith et al.,
2006; Nomura et al., 2007) and se-
quenced directly in an ABI310 genetic
analyzer (Applied Biosystems, Foster
City, CA). Direct sequencing of the
most severely affected patient disclosed
compound heterozygous nonsense/
frameshift mutations: p.R501X and
c.3321delA (GenBank NM_002016;
Figure 2). The same compound hetero-
zygous mutations were found in his
sister. The mother and father were
heterozygous for p.R501X and
c.3321delA, respectively. The screen-
ing for p.R501X, c.2282del4,
c.3321delA, and p.S2554X in
additional four Japanese IV patients
revealed negative results. The hetero-
zygous mutation c.3321delA was
found only in one Japanese AD patient
but not in 200 ethnically matched
controls by sizing of fluorescently la-
beled PCR fragment on an ABI310
genetic analyzer, as described pre-
viously (Nomura et al., 2007). In addi-
tion, p.R501X and c.2282del4 were
also not detected in 200 Japanese
controls by restriction digestion as
described previously (Smith et al.,
2006).
As this Japanese family had no
European ancestry, it was of conside-
rable interest to learn if p.R501X muta-
tion, which is common in Europe, was
present on the same chromosomal
haplotype in this family (Sandilands
et al., 2007). Specifically, in Europeans,
p.R501X is carried on one of the two
known 11-repeat filaggrin size variant
alleles (designated FLG8þ carrying a
duplicated repeat 8), and this mutant
allele also carries a non-synonymous
single nucleotide polymorphism in fi-
laggrin repeat 10, p.R3564L (Sandi-
lands et al., 2007). Direct sequencing
showed that all family members here
were homozygous for the 12-repeat
filaggrin allele FLG8þ 10þ , which con-
sists of duplicated repeat 8 and dupli-
cated repeat 10 (Sandilands et al.,
2007). Furthermore, all family members
were homozygous for a different single
nucleotide polymorphism involving the
same codon in repeat 10, p.R3564H.
Therefore, the Japanese p.R501X muta-
tion identified here is (a) on a different
haplotype from that found in Europeans
and (b) uncommon in Japan, having
been excluded from 200 controls and
4 IV patients here and from 191
Japanese controls and 143 Japanese
AD patients previously (Palmer et al.,
2006; Nomura et al., 2007). As
p.R501X (DNA change CGA to TGA)
is consistent with being a CpG mutation
hotspot (Cooper and Krawczak, 1993),
this may occur as a de novomutation in
all populations, as well as being a
prevalent, ancestral mutation in Eur-
opeans.
Previous studies revealed a number
of rare and prevalent European muta-
tions with a combined heterozygous
carrier frequency of about 9% (Sandi-
lands et al., 2007). These results predict
a high incidence of one IV patient in
about 300 of the population, which
agrees fairly well with the results of a
clinical survey of 6,051 English school
children, where 1 in 250 had overt IV,
presumably due to homozygous or
compound heterozygous mutations
(Wells and Kerr, 1966). Although a
wide survey of the prevalence rate ofAbbreviations: AD, atopic dermatitis; IV, ichthyosis vulgaris
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Japanese IV has not yet been per-
formed, the disease is considered to
be one of the most frequent single-gene
disorders in Japan. As the European
mutations are not very common in
Japan, it is likely that further mutations
exist that are specific to this population
(Sandilands et al., 2007).
Ichthyosis vulgaris shows a semido-
minant inheritance pattern: a mild
phenotype is heterozygous and a severe
phenotype is homozygous or com-
pound heterozygous for FLG mutations
(Smith et al., 2006). In this study,
compound heterozygous mutations
p.R501X and c.3321delA were identi-
fied in two individuals with a severe
phenotype. Interestingly, the mildly
affected mother and clinically normal
father were a carrier of p.R501X and
c.3321delA, respectively. Thus, intrafa-
milial phenotypic variability of the
disease was observed here in this
semidominant inherited trait.
Filaggrin plays a key role in terminal
differentiation of the epidermis and
formation of the skin barrier. Recent
genetic evidence suggests that p.R501X
and c.2282del4 mutations in FLG are
important predisposing factors for AD
as well as for eczema-associated asth-
ma (Palmer et al., 2006). In several
additional cohorts from European po-
pulation, these common FLG variants
were also shown to be associated with
AD, especially in cases with an early
age of onset and a poor prognosis
(Weidinger et al., 2006; Barker et al.,
2007; Stemmler et al., 2007). Recently,
c.3321delA and p.S2554X mutations
were shown to be carried by 5.6% of
a Japanese AD cohort (Nomura et al.,
2007). Here, we have identified FLG
mutations p.R501X and c.3321delA in
a Japanese family with IV who also had
AD. Interestingly, this family has a
combination of the common FLG muta-
tions reported from Europe and Japan,
respectively. Further investigations will
be necessary to clarify the worldwide
population genetics of FLG mutations
more accurately.
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Figure 1. Clinical features of the most severe patient in the present family with IV complicated by AD.
(a) Fine superficial scaling on the extensor surfaces of the lower legs at the age of 7 years, showing a
typical appearance of IV. (b) Diffuse patches of pruritic erythema on the back at the age of 17 years,




Figure 2. Molecular basis of IV in the present family. Direct sequencing of exon 3 of FLG shows
(a) a heterozygous C4T transition at nucleotide 1501 that converts an arginine residue (CGA) to a
stop codon (TGA); the mutation is designated p.R501X. (b) A heterozygous 1-bp deletion of A at nucleotide
3321 (c.3321delA); the mutation leads to a frameshift and premature stop codon 41-bp downstream.
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TO THE EDITOR
A recent genome-wide association
study (GWAS) conducted by Cargill
et al. (2007) reported an association
between psoriasis and the IL-12b and
IL-23R genes. Their study focused on
the analysis of gene-centric single
nucleotide polymorphisms (SNPs) iden-
tifying four non-HLA SNPs associated
with psoriasis in a North American
population. Our study confirms these
findings in a single-point association
study genotyping these four SNPs (two
in the IL-12b gene and two in the IL-
23R gene) in 597 UK psoriasis patients
with onset of disease at p40 years of
age (type I psoriasis; 53.6% male;
46.4% female; mean age of onset 19.8
years; 58.8% patients HLA-Cw6-posi-
tive). Recruitment of type I psoriasis
patients for the case cohort was co-
ordinated through the Dermatology
Centre, Hope Hospital, The University
of Manchester, Manchester, UK. All
patients gave written informed consent
and the study was approved by the
Salford and Trafford Local Research
Ethics Committee and conducted ac-
cording to the Declaration of Helsinki
Principles. Control data were available
from the Wellcome Trust Case Control
Consortium (rs6887695, rs11209026,
and rs7530511) and 1958 British Birth
Cohort study (rs3212227) (Power and
Elliott, 2006). The SNP rs3212227,
located in the IL-12b gene, which
encodes the IL-12b-p40 subunit of the
IL-12 and IL-23, was previously asso-
ciated with the disease in a study of 143
Japanese psoriasis patients and 100
unaffected controls (P¼ 0.035) (Tsunemi
et al., 2002) and also a recent indepen-
dent GWAS of UK psoriasis patients
(P¼0.036) (Capon et al., 2007). Our
findings replicate the associations
found in the US (P¼7.85 1010;
Cargill et al., 2007), Japanese, and UK
cohorts with association to the same
allele (P¼0.003; Table 1) where risk
was conferred by carriage of two copies
of the major allele (genotype AA) with
an odds ratio of 1.38 (95% CI
1.14–1.68; P¼ 0.0004).
The GWAS found association to a
second SNP rs6887695 in IL-12b
(Cargill et al., 2007) and reported a
haplotypic association. We also de-
tected association to rs6887695, con-
firming this single-point genotypic
association (P¼0.001; Table 1) on the
basis of a dominant model of inheri-
tance for the major allele (genotype
GG) with an odds ratio of 1.72 (95% CI
1.18–2.56; P¼0.0016); however, we
reported low linkage disequilibrium
correlation with r2¼ 0.21 (calculated
using the genetic analysis software
HelixTree; Golden Helix Inc., Boze-
man, Montana) between these SNPs in
the patient cohort and thus did not
conduct any haplotype analysis.
Cargill et al. (2007) also investigated
the IL-23 cytokine-related proteins (as
IL-23R shares the IL-12b-p40 protein
subunit) and identified two further SNPs
in the IL-23 receptor gene (IL-23R)
associated with psoriasis. SNP
rs7530511 was detected in the single-
point marker analysis of the GWAS
with a P-value of 0.006, whereas SNP
rs11209026 showed significant associa-
tion to the disease in combination with
this marker in an estimated haplotype
analysis (P¼ 3.3106) (Cargill et al.,
2007), a finding replicated in the
GWAS of UK psoriasis patients
(P¼0.00014) (Capon et al., 2007).
Our study also confirms genotypic
association to these markers with
Po0.001 and P¼ 0.001 for
rs11209026 and rs7530511 SNPs, re-
spectively (Table 1), with a dominant
model of inheritance for the major
allele in rs11209026 (genotype GG)
with odds ratio of 1.67 (95% CI
1.20–2.37; P¼0.0008) and risk con-
Abbreviations: GWAS, genome-wide association study; IL-23R, IL-23-receptor; SNP, single nucleotide
polymorphism.
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